Stock Events

Stock Events

TransCode Therapeutics (RNAZ) Q4 2024 Earnings

14NovConfirmed

Q4 2022

Q2 2024

Q3 2024

Q4 2024

-16.17

-10.78

-5.39

0

Details

Expected EPS

-16.17

Actual EPS

-5.28

Surprise EPS

10.89

Surprise Percent

+67.35%

Description

TransCode Therapeutics (RNAZ) has reported earnings of -5.28 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.